On 24 June 2021, Chardan hosted a Leadership Call with management from SQZ Biotechnologies (unrated), including Dr. Armon Sharei, CEO and founder, and Teri Loxam, CFO. SQZ is a clinical-stage company developing cell-based therapies designed to direct or modulate antigen-specific immunity in oncology, autoimmune, and infectious disease.

Watch the replay of this event

**This event is for current or prospective relationships of Chardan.